期刊文献+

湘雅医院细菌耐药性监测 被引量:17

Surveillance of Bacterial Resistance in Clinical Isolates from Xiangya Hospital
原文传递
导出
摘要 目的了解中南大学湘雅医院2009年临床常见分离菌的分布及耐药性。方法采用Vitek 2全自动微生物鉴定分析系统对临床分离菌株进行鉴定及药敏试验,WHONET 5.4统计软件对数据进行分析。结果 7 841株临床分离菌株中,革兰阳性菌占28.5%(2 237/7 841),革兰阴性菌占55.7%(4 369/7 841),真菌占15.8%(1 235/7 841)。革兰阳性球菌居前五位的分别为凝固酶阴性葡萄球菌、金黄色葡萄球菌、粪肠球菌、屎肠球菌和血液链球菌。耐甲氧西林金黄色葡萄球菌(MRSA)和凝固酶阴性葡萄球菌(MRCNS)的检出率分别为63.7%和67.2%,未发现万古霉素耐药或中介的葡萄球菌,但分离到万古霉素耐药肠球菌(VRE)7株。革兰阴性杆菌中分离率居前五位的依次为铜绿假单胞菌、大肠埃希菌、鲍曼不动杆菌、肺炎克雷伯菌和阴沟肠杆菌。肠杆菌科细菌中,大肠埃希菌、肺炎克雷伯菌、阴沟肠杆菌对碳青霉烯类抗生素的耐药率最低(<2.3%),大肠埃希菌、肺炎克雷伯菌对哌拉西林/他唑巴坦、头孢哌酮/舒巴坦的耐药率<13.0%,而阴沟肠杆菌对哌拉西林/他唑巴坦、头孢哌酮/舒巴坦的耐药率分别达40.0%和28.4%。非发酵菌中,铜绿假单胞菌对美洛培南、头孢哌酮/舒巴坦的耐药率较低,分别为9.1%和12.4%;鲍曼不动杆菌对头孢哌酮/舒巴坦、左氟沙星及氨苄西林/舒巴坦耐药率较低,分别为7.0%、7.6%和16.3%,对美洛培南耐药率达28.8%;对其他抗菌药物耐药率均超过40%。结论该院常见病原菌以革兰阴性杆菌为主;病原菌对多种临床常用抗菌药物耐药,尤其是对万古霉素耐药肠球菌的出现及对碳青霉烯类耐药非发酵菌的增加,应引起临床高度重视,及时采取有效措施,控制耐药菌在医院内播散和暴发流行。 Objective To investigate the distribution and antibiotic resistance of clinical isolates collected from Xiangya Hospital of Central South University in 2009. Methods The isolates and their susceptibilities were determined by automatic microorganism analytical system VITEK-2.All the data were analyzed by WHONET 5.4 software. Results A total of 7,841 isolates were collected,of which gram positive cocci,gram negative organisms and fungus accounted for 28.5%(2,237/7,841),55.7% (4,369/7,841),and 15.8%(1,235/7,841),respectively.The first 5 gram positive cocci were coagulase negative Staphylococcus(CNS),Staphylococcus aureus,Enterococcus faecalis,Enterococcus faecium and Streptococcus sanguis.Methicillin resistant strains in S.aureus(MRSA) and coagulase negative Staphylococcus(MRCNS) accounted for 63.7% and 67.2%,respectively.No staphylococcal strain was intermediate or resistant to vancomycin.Seven strains of Enterococcus spp.were resistant to vancomycin(VRE).The first 5 gram negative bacilli were Pseudomonas aeruginosa,Escherichia coli,Acinetobacter baumannii,Klebsiella pneumonia,and Enterobacter cloacae.The strains of Enterobacteriaceae,like E. coli,K.pneumonia,and E.cloacae,had very low resistance rates to carbopenems(2.3%).The resistance rates of E.coli and K.pneumonia to piperacillin/tazobactam or cefoperazone/sulbactam were less than 13.0%.The resistance rates of E.cloacae to piperacillin/tazobactam and cefoperazone/sulbactam were 40.0% and 28.4%,respectively.Among non-fermenter,the resistance rates of P.aeruginosa to meropenem and cefoperazone/sulbactam were 9.1% and 12.4%,respectively.The resistance rates of A.baumannii to cefoperazone/sulbactam,levofloxacin and and ampicillin/ sulbactam were 7.0%,7.6% and 16.3%,respectively.The resistance rate of A.baumannii to meropenem was high(28.8%) and was even higher to other commonly used antibiotics(40%). Conclusions Gram negative bacilli are still the major isolates and multidrug resistance is serious in our hospital.Clinical doctors should pay special attention to the increasing strains of vacomycin resistant Enterococcus spp. and carbapenems-resistant non-fermenter.It is urgent that effective control measures should be taken to prevent dissemination and outbreak of these stains.
出处 《实用预防医学》 CAS 2011年第10期1823-1826,共4页 Practical Preventive Medicine
基金 湖南省科技厅基金资助项目(编号:08FJ3175) 湖南省自然科学基金资助项目(编号:10JJ5027)
关键词 耐药性监测 抗菌药物 药敏试验 多重耐药菌 Surveillance of bacterial resistance Antimicrobial agent Bacterial susceptibility testing Multi-drug resistant bacteria
  • 相关文献

参考文献15

  • 1Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo- beta - lactarnase gene, bla ( NDM - 1 ), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India[J ]. Antimicrob Agents Chemother, 2009,53(12) :5046 - 5054.
  • 2Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study[J]. Lancet Infect Dis, 2010,10(9) :597 - 602.
  • 3肖永红.卫生部全国细菌耐药监测网(Mohnarin)介绍[J].中国抗生素杂志,2008,33(10):577-578. 被引量:27
  • 4CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement[S]. M100 S19, 2009.
  • 5邹明祥,范学工,梁湘辉,刘文恩,李宪.2003年湘雅医院临床分离菌的分布及耐药性分析[J].实用预防医学,2006,13(2):241-243. 被引量:12
  • 6汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:398
  • 7艾效曼,陶凤蓉,陈东科,许宏涛,胡云建.2009年北京医院细菌耐药性监测[J].中国感染与化疗杂志,2011,11(2):141-146. 被引量:19
  • 8Yco JS, Byeon J, Yang J, et al. High prevalence of extended spectrum beta- lactamases and plasmid - mediated AmpC beta - lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea [J]. Diagn Microbiol Infect Dis, 2010,67(3):261 -265.
  • 9Sirrmer PJ, Zhanel GG, Pitout J, et al. Prevalence and characterization of extended- spectrum beta - lactamase and AmpC beta lactamase producing Escherichia coil: results of the CANWARD 2007 2009 study[J]. Diagn Microbiol Infect Dis, 2011,69(3) :326 - 334.
  • 10戴春梅,周建党,伍勇,漆涌.重症监护病房医院感染病原菌分布及其耐药性分析[J].中南大学学报(医学版),2006,31(2):277-280. 被引量:28

二级参考文献48

共引文献476

同被引文献105

引证文献17

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部